This paper was converted on www.awesomepapers.org from LaTeX by an anonymous user.
Want to know more? Visit the Converter page.

Deep Learning Models for Atypical Serotonergic Cells Recognition

Daniele Corradetti Alessandro Bernardi Renato Corradetti
Abstract

Background: The serotonergic system modulates brain processes via functionally distinct subpopulations of neurons with heterogeneous properties, including their electrophysiological activity. In extracellular recordings, serotonergic neurons to be investigated for their functional properties are commonly identified on the basis of “typical” features of their activity, i.e. slow regular firing and relatively long duration of action potentials. Thus, due to the lack of equally robust criteria for discriminating serotonergic neurons with “atypical” features from non-serotonergic cells, the physiological relevance of the diversity of serotonergic neuron activities results largely understudied.

New Methods: We propose deep learning models capable of discriminating typical and atypical serotonergic neurons from non-serotonergic cells with high accuracy. The research utilized electrophysiological in vitro recordings from serotonergic neurons identified by the expression of fluorescent proteins specific to the serotonergic system and non-serotonergic cells. These recordings formed the basis of the training, validation, and testing data for the deep learning models. The study employed convolutional neural networks (CNNs), known for their efficiency in pattern recognition, to classify neurons based on the specific characteristics of their action potentials.

Results: The models were trained on a dataset comprising 27,108 original action potential samples, alongside an extensive set of 12 million synthetic action potential samples, designed to mitigate the risk of overfitting the background noise in the recordings, a potential source of bias. Results show that the models achieved high accuracy and were further validated on ”non-homogeneous” data, i.e., data unknown to the model and collected on different days from those used for the training of the model, to confirm their robustness and reliability in real-world experimental conditions.

Comparison with existing methods: Conventional methods for identifying serotonergic neurons allow recognition of serotonergic neurons defined as typical. Our model based on the analysis of the sole action potential reliably recognizes over 94% of serotonergic neurons including those with atypical features of spike and activity.

Conclusions: The model is ready for use in experiments conducted with the here described recording parameters. We release the codes and procedures allowing to adapt the model to different acquisition parameters or for identification of other classes of spontaneously active neurons.

keywords:
Deep Learning Models , Serotonergic Neurons , Convolutional Neural Networks , Dorsal Raphe Nucleus , Spike Recognition
PACS:
87.19.L , 87.19.lv , 87.85.dm , 07.05.Mh , 87.85.Tu
journal: Journal of Neuroscience Methods
\affiliation

[inst1]organization=Grupo de Fisica Matematica, Instituto Superior Tecnico,addressline=Av. Rovisco Pais, city=Lisboa, postcode=1049-001, country=Portugal

\affiliation

[inst2]organization=Departamento de Matematica, Universidade do Algarve,addressline=Campus de Gambelas, city=Faro, postcode=8005-139, state=Faro, country=Portugal

\affiliation

[inst3]organization=Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence,addressline=Viale G. Pieraccini 6, city=Firenze, postcode=50139, state=Toscana, country=Italy

1 Introduction

Activity of serotonergic neurons is known to regulate a wealth of autonomic and higher functions in mammals (Steinbusch et al., 2021; Faulkner and Deakin, 2014; Pilowsky, 2014; Lesch et al., 2012; Monti, 2011). Present knowledge of the physiological and pharmacological properties of serotonergic neurons is mostly based on electrophysiological recordings of neuronal activity from raphe nuclei of laboratory animals both in vivo and in vitro. However, most of recordings have been performed on neurons whose serotonergic identity was based on criteria that were empirically developed in the years to restrict the investigations to recordings from neurons that displayed very typical activity. For serotonergic neurons, the accepted criteria require the concomitant regularity of firing, broad action potential and, when pharmacological assays were allowed by the experimental design, sensitivity to serotonin1A receptor agonists that typically produce reversible slowing or cessation of neuron firing. When recordings are conducted in slices under microscopy guidance, the large size of serotonergic neuron soma could be used as an additional criterion. Adhering to these strict criteria for serotonergic neuron identification, however, results in a selection bias that has limited the studies to the “typical” neurons which might underrepresent the variety of serotonergic neuron population. The implication of serotonin neuron activity in behavioural tasks in mice has been studied using selective optogenetic activation and recording from raphe neurons in vivo (Liu et al., 2014) as well as with one-photon calcium imaging (Paquelet et al., 2022). Interestingly, the latter study revealed anatomically defined subpopulations of DRN serotonin neurons with different activity and projecting to either reward-related or anxiety-related brain areas. This confirmed previous evidence for the existence of subpopulations of serotonergic neurons with distinctive neurochemical and pharmacological properties as well as firing patterns, emerged in the course of the past 40 years of dedicated research (e.g. Calizo et al., 2011; Paquelet et al., 2022; see also in Gaspar et al., 2012; Andrade and Haj-Dahmane, 2013; Commons, 2020). For instance, using in vitro recordings from dorsal raphe nucleus the possibility that serotonergic neurons display also irregular firing or peculiar rhythmic fluctuations in firing activity has been described since early recordings both in vivo and in vitro (Mosko and Jacobs (1974, 1976) and more recently confirmed with recordings of serotonergic neurons from transgenic mice selectively expressing fluorescent proteins in serotonergic neurons (Mlinar et al, 2016). Thus, the principal drawback of the intra-experiment recognition of 5-HT neurons is that serotonergic neurons displaying atypical activity or spikes narrower than expected are discarded and their pharmacological and physiological characteristics remain elusive. In addition, in the course of our research on genetically fluorescent serotonergic neurons (Montalbano et al., 2015; Mlinar 2016) we also noticed the existence of non-serotonergic (non-fluorescence labelled) neurons with regular activity and relatively broad spikes whose duration often overlaps that of action potentials recorded in serotonergic neurons. Thus, in “real life” experimental conditions the activity characteristics of a non-neglectable number of serotonergic and non-serotonergic neurons could overlap and adherence to the above-mentioned strict criteria for identification of typical serotonergic neurons has the advantage to ensure a reasonable homogeneity of the population under study, in spite of the selection bias introduced. On the other hand, the characteristics of what we define “atypical” serotonergic neurons remain understudied.

In the present work we have taken advantage of the recordings present in our internal database and obtained from transgenic mice selectively expressing fluorescent proteins in serotonergic neurons to develop deep-learning based models for recognition of serotonergic and non-serotonergic neurons with relatively high accuracy and that can be implemented in the recording programs to quickly help the experimenter in the decision of continuing the recording or to change the experimental design, should an atypical serotonergic or non-serotonergic neuron be identified.

2 Material and Methods

2.1 Source database

To train, test and validate our deep-learning based models we used the original recordings from our internal database built in the occasion of our studies in which we described the firing characteristics of genetically identified dorsal raphe serotonergic neurons in brain slices. Serotonergic and non-serotonergic neurons were thus identified on the basis of a parameter independent from their electrophysiological features, i.e., on serotonergic system-specific fluorescent protein expression (serotonergic) or lack of expression (non-serotonergic). In our original articles (Mlinar et al., 2016; Montalbano et al., 2015) we detailed the procedure to obtain the three transgenic mouse lines with serotonergic system-specific fluorescent protein expression used in the present work: Tph2::SCFP; Pet1-Cre::Rosa26.YFP ; Pet1-Cre::CAG.eGFP.

2.2 Loose-seal cell-attached recordings

Detailed description of the electrophysiological methods and of the measures for improving reliability of loose-seal cell-attached recordings has been previously published (Montalbano et al., 2015; Mlinar et al., 2016). In brief, mice (4-28 weeks of age) were anesthetized with isofluorane and decapitated. The brains were rapidly removed and dissected in ice-cold gassed (95% O2 and 5% CO2) ACSF composed of: 124 mM NaCl, 2.75 mM KCl, 1.25 mM NaH2PO4, 1.3 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, 11 mM D-glucose. The brainstem was sliced coronally into 200 µm thick slices with a vibratome (DSK, T1000, Dosaka, Japan). Slices were allowed to recover for at least 1 h at room temperature and then were individually transferred to a submersion type recording chamber and continuously superfused at a flow rate of 2 ml min-1 with oxygenated ACSF warmed to 37°C by a feedback-controlled in-line heater (TC-324B / SF-28, Warner Instruments, Hamden, CT). Slices were allowed to equilibrate for 10-20 min before the beginning of the recording. To reproduce in brain slices noradrenergic drive that facilitates serotonergic neuron firing during wakefulness (Baraban and Aghajanian, 1980; Levine and Jacobs, 1992), ACSF was supplemented with the natural agonist noradrenaline (30 μ\muM) or with the α\alpha1 adrenergic receptor agonist phenylephrine (10 μ\muM; Vandermaelen and Aghajanian, 1983). Neurons within DRN were visualized by infrared Dodt gradient contrast video microscopy, using a 40X water-immersion objective (N-Achroplan, numerical aperture 0.75, Zeiss, Göttingen, Germany) and a digital CCD camera (ORCA-ER C4742-80-12AG; Hamamatsu, Hamamatsu City, Japan) mounted on an upright microscope (Axio Examiner Z1; Zeiss) controlled by Axiovision software (Zeiss). Loose-seal cell-attached recordings were made from fluorescent protein-expressing or not expressing neurons, visually identified by using Zeiss FilterSet 46 (eGFP and YFP, excitation BP 500/20, emission BP 535/30) or Zeiss FilterSet 47 (CFP, excitation BP 436/20, emission BP 480/40). Fluorescence was excited using a Zeiss HXP 120 lamp. Patch electrodes (3-6 MΩ\Omega) were pulled from thick-walled borosilicate capillaries (1.50 mm outer diameter, 0.86 mm inner diameter; Corning) on a P-97 Brown-Flaming puller (Sutter Instruments, Novato, CA) and filled with solution containing (in mM): 125 NaCl, 10 HEPES, 2.75 KCl, 2 CaCl2 and 1.3 MgCl2, pH 7.4 with NaOH. After positioning the pipette, development of loose-seal was monitored by using a voltage-clamp protocol with holding potential of 0 mV and test pulse of 1 mV / 100 ms, repeated every second. Weak positive pressure was released and gentle suction was slowly applied until detected spikes increased to 50 - 100 pA peak-to-peak amplitude. In some experiments this procedure was repeated during recording to increase signal to noise ratio. Corresponding seal resistance was in 10 to 20 MΩ\Omega range. Recordings were made using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA) controlled by Clampex 9.2 software (Molecular Devices). Signals were low-pass filtered with a cut-off frequency of 5 kHz (Bessel) and digitized with sampling rate of 40 kHz (Digidata 1322A, Molecular Devices). After the recording, images of recorded neuron were acquired to document the expression of the fluorescent marker in the recorded neuron.

2.3 Offline Analysis of recordings

Detection of spikes was performed using event detection routine of Clampfit 9.2 software. Spike duration (width) was determined from the shape of averaged action potential by measuring the interval between the spike upstroke and the downstroke (or second downstroke, whenever present) hereby named UDI (Upstroke-Downstroke Interval) for convenience (see Fig. 6; see also Fig. 3 in Mlinar et al., 2016).

3 A Deep Learning Model

Recognizing serotonergic cells is a binary classification problem, i.e., serotonergic vs. non-serotonergic cells, for which deep learning (DL) algorithms and, more specifically, the use of convolutional neural networks (CNN) have yielded excellent results. Notably, CNN are inspired by the organization of the animal visual system, particularly the human brain, and excel at tasks like image feature extraction, which is fundamental for recognition purposes (Liu, 2018). They employ mechanisms such as feedforward inhibition to alleviate issues like gradient vanishing, enhancing their effectiveness in complex pattern recognition tasks (Liu et al, 2019). With these considerations in mind, we have chosen to use a CNN architecture even in the apparently unconventional context of numerical pattern recognition, i.e., the recorded signal of a neuronal cell. The inspiring idea behind this choice is to leverage the ability of CNNs to amplify numerical patterns that occur at different scales, in this case within time intervals that are orders of magnitude smaller than the entire examined signal. In fact, this is a characteristic typical of neuronal spikes, where the maximum peak impulse can occur within a scale of 1 ms, while the firing period, i.e., the time interval between two consecutive spikes, can be two orders of magnitude greater.

3.1 Preliminary approaches and definition of appropriate parameters for developing the model

Starting from the assumption that two factors are typically relevant in recognizing serotonergic cells, namely the specific shape of the action potential together with its repetitiveness and firing frequency, we initially decided to consider time segments of 7 seconds as training data for the neural network. This ensured an adequate number of action potentials to evaluate their consistency and periodicity. After several attempts in this direction, however, we realized that the importance of the cell’s action potential shape was so predominant that the information obtained from analyzing the firing periodicity alone was not sufficient to compensate for the accuracy gained by focusing on the individual action potential.

Our first preliminary analysis was done on 108 serotonergic cells and 45 non-serotonergic cells. Every action potential for the training consisted in the recording of 7 ms taken from 2 ms before the detection threshold to 5 ms after. While the final accuracy of the resulting models was fairly high, ranging from 94.3% to 99.3%, further analysis on non-homogeneous data, i.e. data from neurons whose identity was kept unknown to the model and were collected on experimental days different from those used for the training and evaluation of the models, showed a much lower accuracy, which was a strong sign of the overfitting. Further investigation allowed to identify an important source of overfitting in the background noise of the recordings which, having a specific signature, the model learned to incorporate in the recognition of the neuron types. Thus, models trained with action potentials embedded in 7 ms time-segments learned how to classify the spikes on the basis of the background noise instead of the peculiar shape of the event.

Therefore, we decided to reduce the impact of the background noise present in the samples by limiting the time-window of action potential analysis to 4 ms. This solution worked well, since we had a comparable accuracy of the metrics on non-homogeneous data.

Another very efficient solution for expanding the training data, beside splitting the samples in different segments, was given by the generation of a synthetic data set for which we develop a very specific procedure (see section 3.2) that combines smoothed action potentials signals along with real noise masks. To this purpose, we produced 12M synthetic action potentials from a pool of 600 different noise backgrounds, thus reducing the impact that such noise could have in the training. The training on synthetic data led to an improvement on all accuracy types on non-homogeneous data (e.g. from binary accuracy 0.9125 to 0.9375, from AUC 0.8976 to 0.9255 and from F1-Score 0.8679 to 0.9056, see Fig. 9 for more details). Besides the specific improvement in model performance, it is important to note the utility of the synthetic model in monitoring sources of overfitting arising from noise signatures in the recordings. More specifically, the difference in accuracy on non-homogeneous data between the biological model and the synthetic model provides a rough estimate of the overfitting in the biological model resulting from noise signatures. This is highly significant when determining how additional experiments with different noise signatures could improve the model.

Refer to caption
Figure 1: Summary of the various steps used to implement the model from recorded signals: from neuronal cell the signal is sampled at 40 kHz and recorded as .abf file, then the all events are selected and sent to 10 neural networks with the above architecture for classification (only difference between the architectures is the value of the 2D convolutional kernel with ranges between 20 to 30).

3.2 Data used for originating and validating the final model

Original Training Data

The original data for the training, validation and testing of the models consisted in 43,327 action potential samples extracted from 108 serotonergic cells and 45 non-serotonergic cells. Since the two classes were unbalanced (29,773 serotonergic and 13,554 non-serotonergic) we undersampled the serotonergic class, to obtain a more balanced dataset for training. Therefore, the training set data consisted in 13,554 action potentials from serotonergic cells, and 13,554 action potentials from non-serotonergic cells. In all cases, the triggering threshold of the event was -50 pA and the spike was then sampled 1 ms before the triggering threshold until 3 ms after (see Figs. 1,2). Since the sampling rate of the original recordings was 40 kHz, every action potential sample consists of 160 values. All the samples were then randomly subdivided into 18,975 for training, 4,066 for validation and 4,067 for testing.

Refer to caption
Figure 2: Example on how single events were isolated and selected. The image depicts the recording of the serotonergic cell A140313#073 and the 4 ms event of triggered at point 1007585, i.e. at 25.189 sec.
Non-homogeneous Data

The non-homogeneous data consisted in 24,616 samples extracted from a new set of 55 serotonergic cells (18,595 action potentials) and 27 non-serotonergic cells (6,021 action potentials) collected in experimental days not used to obtain the training data, thus with different signal noise. These data were never part of the training set, nor validation, nor testing set during the training. Furthermore, the identity of the neurons from which these data were obtained was unknown to the model. Non-homogeneous data were therefore used as an additional, independent, test for the already trained model to assess its robustness when cells have a noise signal never encountered by the model.

Synthetic Data

The synthetic data consisted in 12,700,600 action potentials samples of 160 points (simulating 4 ms at 40 kHz of sampling), 6,675,300 of which emulated action potentials from serotonergic cells and 6,025,300 from non-serotonergic action potentials. From the original training data recordings we extracted 600 noise masks (see e. g. Fig. 3) from a selection of which were randomly applied to the biological action potentials thus obtaining the synthetic data (see e. g. Fig. 4). The purpose of generating the synthetic data, besides plain data augmentation for higher accuracy, is also to provide an estimate of the overfitting of the biological model based on the noise signature of the data.

The generation of the synthetic data was done according the following procedure. Each original training data sample is smoothed through averaging, i.e. the values of the smoothed sample {ym}\left\{y^{\prime}_{m}\right\} with m{1,,160}m\in\left\{1,...,160\right\}, are given as the averages of the values of the original sample {ym}\left\{y_{m}\right\} by

ym=(ym1+y+my)m+13.y^{\prime}_{m}=\frac{\left(y_{m-1}+y{}_{m}+y{}_{m+1}\right)}{3}. (1)

The reason for this 3-point averaging preprocessing of the signal is due to the need to combine two requirements: the need to smooth the original signal from the specific noise of the recording, and the need to maintain the structure of the signal. The rapid depolarization of the cell is such that the most relevant data of the action potential recording are often formed in a few tenths of a millisecond, i.e., most useful informations are supposedly condensed in about a dozen of recording points. This means that considering nn-point averaging with n>3n>3 could undermine the fundamental information inside the signal, while n=2n=2 might not be sufficient to remove the background noise. After the averaging process, the values of smoothed action potential {ym}\left\{y^{\prime}_{m}\right\} are added to the values of randomly chosen noise mask {nm(k)}\left\{n_{m}^{(k)}\right\} where k{1,,600}k\in\left\{1,...,600\right\} is randomly chosen. The final synthetic sample is thus obtained as the sample {y(k)}m\left\{y^{(k)}{}_{m}\right\} with

y(k)=mym+αnm(k),y^{(k)}{}_{m}=y^{\prime}_{m}+\alpha\cdot n_{m}^{(k)}, (2)

where α[0.2,0.4]\alpha\in[0.2,0.4] is a randomly generated “dumping coefficient” experimentally found around 0.30.3 to modulate the noise. The choice of this coefficient requires some clarification. Indeed, the coefficient dumps the noise intensity to synthesize more physiologically plausible spike waveforms. First, the background noise was not completely removed when averaging action potentials, just smoothed with a 3-point average. Thus directly adding the full noise mask would excessively boost the background noise compared to the original recording. Moreover, the original noise does not influence all points of the signal equally, but is more pronounced in slower changing current regions. Applying the raw noise mask tends to produce unrealistic action potential shapes, e.g. double bottoms. The dumping coefficient between 0.20.2 and 0.40.4 was deemed a suitable range by visual inspections by an expert author with over 30 years of experience on serotonergic action potential recordings.

Refer to caption
Figure 3: Examples of noise masks collected from the recordings of cell A140724#065 (on the left) and A160127#015 (on the right).
Refer to caption
Figure 4: Example of 4 synthetic action potentials generated by the event triggered at 1007585, i.e. 25.189 sec, of the serotonergic cell A140313#073. Top trace: the original recording of the event. The panels report four action potential obtained by processing the original trace with different noise masks (see methods).

3.3 Model Description

In accordance with the origin of our dataset, we developed two distinct models, namely the “biological” model (trained only over original data) and the “synthetic” model (trained only on synthetic data). The biological model underwent training, validation, and testing using the original training data, which comprises 27,108 action potential samples after the balancing of the classes. Conversely, the synthetic model was trained, validated, and tested utilizing synthetic data, encompassing 12,700,600 action potential samples.

Fig. 1 summarizes the various steps used to implement the model from recorded signals. The architecture of the models is a sequence of layers commonly used in deep learning, specifically in the context of convolutional neural networks (CNNs) for image or signal processing. We implemented the architecture using the Keras libraries in TensorFlow 2. The model of the neural network consists of a normalization layer for stabilizing the learning process and reducing training time; two repetitions of a 2D convolutional layer with 32 filters and a max pooling layer with a pool size of (2x1); a flatten layer to connect to a dropout layer and dense layers with 2 output units used for binary classification. Activation functions of the convolutional layers are the ReLU, while for the dense layer we used the classic sigmoid (see Table 1 for a summary of the model).

Layer (type) Output Shape Param #
Layer Normalization (None, 160, 2, 1) 320
Conv2D (None, 141, 2, 32) 672
MaxPooling2D (None, 70, 2, 32) 0
Conv2D (None, 51, 2, 64) 41024
MaxPooling2D (None, 25, 1, 64) 0
Flatten (None, 1600) 0
Dropout (None, 1600) 0
Dense (None, 2) 3202
Total Params 45218
Table 1: Summary of the CNN architectural model with kernel 20 used for the neural network. Other models follow the same architectural structure and change only for the dimension of the kernel.

For training we chose the ”binary crossentropy” loss function, which is standard for binary classification problems, while the optimizer was ”Adam” (Adaptive Moment Estimation) as these are common choices. A special treatment was devoted to the kernel of the 2D convolutional layers. Indeed, since the kernel of these layers express the ability of the convolutional process in enlarging a specific portion of the pattern, we explored a range of possible kernels between 1 to 31. All models were trained on 25 epochs with a batch size of 64 and their test accuracy ranged from 88.3% (model with kernel 1) to 98.4% (model with kernel 23) with a test loss of 0.2641 and 0.05524. To enhance the robustness of the model, instead of selecting a single kernel and using one model for inference, we selected all models with kernels ranging between 20 and 30 and took the consensus between the models. This technique ensures more stability in the overall architecture and is often considered best practice. Since this article presents a method rather than offering a specific optimized deep learning model, we did not systematically search for a specific architecture other than the one above which is a standard. However, we explored a few different architectures with varying numbers of layers and neurons per layer. Nevertheless, the improvement in accuracy was not enough to justify adopting a more complicated architecture. At this stage, to our understanding, acquiring more data represents the most relevant advancement for achieving a better model. Nevertheless, since this article is just a proof of concept, we leave open the possibility of future research into the most suitable architecture for this problem.

Finally, it is worth noticing that while the training of the biological model did not require any specific adjustment, the synthetic model, involving >> 12M action potential samples required a continuous learning implementation, where the model was trained over 200 training sessions of 63,450 synthetic action potential samples.

3.4 Assessment of Accuracy and Sensitivity

For the assessment of the models we used the following metrics: Accuracy, Sensitivity at Specificity 0.5, Area Under the Curve (AUC), F1-Score and the Confusion Matrix.

  • 1.

    Accuracy measures the proportion of total predictions (both serotonergic and non-serotonergic cells) that the model correctly identifies, i.e.

    Accuracy=(True Positives+True Negatives)/Total Samples.Accuracy=\left(\text{True Positives}+\text{True Negatives}\right)/\text{Total Samples}. (3)

    This metric was chosen for identifying if the models are generally effective in classifying both serotonergic and non-serotonergic cells.

  • 2.

    Sensitivity at Specificity measures the sensitivity of the model, i.e.

    Sensitivity=True Positives/(True Positives+False Negatives),Sensitivity=\text{\text{True Positives}}/\text{$\left(\text{True Positives}+\text{False Negatives}\right)$}, (4)

    at a fixed specificity, i.e. True Negatives/(True Negatives+False Positives)\text{\text{True Negatives}}/\text{$\left(\text{True Negatives}+\text{False Positives}\right)$}, which we set at 0.5 . The choice of this metric with this setting ensures that the models are not overly biased towards identifying serotonergic cells at the expense of misclassifying non-serotonergic ones.

  • 3.

    The Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) provides a measure of the model’s ability across classification thresholds, i.e.,

    AUC=01TPR(t),dt,\text{AUC}=\int_{0}^{1}\text{TPR}(t),dt, (5)

    where tt is the threshold, and TPR(t)TPR(t) is the true positive rate at threshold tt. This metric is particularly useful because it is independent of the classification threshold and provides a single measure of performance across all possible levels of sensitivity and specificity.

  • 4.

    The F1-Score is the harmonic mean of precision and sensitivity (recall). The F1-Score takes both false positives and false negatives into account, providing a balanced view of the model’s performance. We considered useful this metric for the measuring the robustness of the model, balancing the trade-off between precision and recall.

  • 5.

    Finally, the Confusion Matrix shows the percentages of True Positives, False Positives, True Negatives, and False Negatives giving a complete feedback of the models. This is a a detailed view that we considered essential for understanding the specific areas where the models need improvements.

All these metrics were used for all the data, i.e. Original Training Data, Non-homogeneous Data and Synthetic Data. In the specific case of the Original Training Data all the metrics were used in the three phases of Training, Validation and Testing. The training phase was developed on 30,328 action potentials selected uniquely for training. The Validation phase, which is used to tune hyperparameters, was on 6,500 action potentials which the model has not seen during training. Finally, the last 6499 action potentials were used for the Testing of the models, and are those on which the true performance of the models is assessed.

3.5 Repository of the Model and Data

We made available in the GitHub respository at GitHub.com/neuraldl/ DLAtypicalSerotoninergicCells.git the following:

  1. 1.

    the .abf recordings of original training data and the non-homogeneous data,

  2. 2.

    the 43,327 single action potentials samples of the original training data stored in .csv files of 160 points,

  3. 3.

    the 24,616 single action potentials samples of the non-homogeneous data stored in .csv files of 160 points,

  4. 4.

    the 12,700,600 million single action potentials samples of the synthetic data stored as numpy vector,

  5. 5.

    the trained models with different kernels,

  6. 6.

    the results of the models,

  7. 7.

    the Python notebooks for training of the models and for inference.

4 Results

In this study we compared the spiking activity of 300 neurons recorded in DRN slices obtained from transgenic mouse lines with serotonergic system-specific fluorescent protein expression.

4.1 Visual discrimination of action potentials

As illustrated in Fig. 5, serotonergic neurons displayed action potentials of different shape and duration that were often difficult to be discriminated from those observed in non-serotonergic neurons. Thus, with the exception of action potentials showing the typical shape and duration of serotonergic neurons (e.g. Fig. 5: traces a1, a2) or of non-serotonergic cells (e.g. Fig. 6: trace b1) both types of neurons may display action potentials similar in width and/or shape. Therefore, the sole duration of the spike, which could be determined online by measuring the upstroke/downstroke interval (UDI) may result not conclusive for immediate serotonergic neuron identification.

Refer to caption
Figure 5: Examples of action potentials recorded from serotonergic and non-serotonergic neurons in slices of dorsal raphe nucleus. A. Fluorescent protein-labelled (serotonergic) neurons: a1,a2: typical action potentials of serotonergic neurons; note the long interval between spike upstroke and downstroke (UDI) highlighted by the shaded area in all traces. a3-a4: recordings from serotonergic neurons displaying spikes of shorter duration. B. Fluorescent protein-unlabelled (non-serotonergic) neurons: b1: typical biphasic spike of short duration from a non-serotonergic neuron; b2-b4: spikes of variable shape recorded from non-serotonergic neurons. Shaded areas indicate the width of the spike measured by UDI (see methods). Note the overlap in action potential width of some serotonergic and non-serotonergic neurons. Traces are averages of 15-50 sweeps. Calibrations 25 pA (polarity inverted); 1 ms.

From our database of recordings we have selected 150 serotonergic neurons labelled by fuorescent proteins and 150 non labelled cells, deemed to be non-serotonergic cells. The distribution of spike width of these two populations is shown in Fig. 6.

Refer to caption
Figure 6: Distribution of spike duration of serotonergic and non-serotonergic neurons. Histograms report the distribution of spike width measured by the interval between spike upstroke and downstroke (UDI) in serotonergic (blue) and non-serotonergic neurons (red) recorded in slices of dorsal raphe nucleus. Note the overlap in spike duration between serotonergic and non-serotonergic neurons. Firing rate (mean ± s.e.m) of serotonergic and non-serotonergic neurons was 2.17 ± 0.08 Hz (range 0.51-5.80 Hz; n=150) and 3.6 ± 0.32 Hz (range 0.07-16.60 Hz; n=150), respectively.

These neurons were chosen on the sole technical characteristic of not showing detectable artefactual transients that could be mistaken by the deep-learning routine as action potentials. From these two populations of neurons we extracted 108 serotonergic and 45 non-serotonergic neurons to implement the training of the Biological Model. In addition, 12 serotonergic neurons from three different experimental days and 10 non-serotonergic neurons from four different experimental days were used for testing the model with data non homogeneous to the training (see methods).

As shown in Fig. 7, the neurons used from training and testing the model 1 are representative of the two (serotonergic and non-serotonergic) populations of neurons.

Refer to caption
Figure 7: Distribution of spike duration recorded from the neurons utilized to develop the model 1. Histograms report the distribution of spike width measured by the interval between spike upstroke and downstroke (UDI) in serotonergic (blue) and non-serotonergic neurons (red) recorded in slices of dorsal raphe nucleus. Firing rate (mean ± s.e.m) of serotonergic and non-serotonergic neurons was 2.29 ± 0.09 Hz (range 0.38-5.08 Hz; n=120) and 2.43 ± 0.33 Hz (range 0.07-9.32 Hz; n=55), respectively.

An additional group of recordings (n=30n=30) from fluorescence identified serotonergic and non-serotonergic neurons, not previously used for the model implementation, were processed by the model 1 to test its ability to recognize cell type from the spike characteristics distilled by the model itself.

4.2 Discrimination with Deep Learning Models

The metrics of both the biological model and the synthetic model were collected over the testing data (original and synthetic) during their training phase, as standard practice in deep learning. Over this data both the biological model and the synthetic model scored >> 98% accuracy. In addition to the standard practice we evaluated the models over non-homogeneous data in order to evaluate possible sources of overfitting arising from noise signatures in the recordings. On this dataset the biological model scored >> 91.2% accuracy showing the existence of some light source of overfitting. As expected the synthetic model showed better results with >> 93.7% accuracy. Overall, we consider the metrics evaluated on non-homogeneous data more indicative and more reliable than those arising from the training data. Indeed, non-homogeneous data not only were unknown to the model, but were also collected on different days than those of the data used for the training.

4.2.1 Results on the Training Data

Biological Model

The biological models, when tested on the original training dataset, showed varying performance metrics. For kernels ranging from 1 to 31, the test loss was observed between 0.26417 (kernel 1) and 0.05006 (kernel 27). Accuracy measurements ranged from 0.88296 (kernel 1) to 0.98401 (kernel 29), as detailed in Fig. 8. The consensus biological model, obtained from models with kernels 20 to 30, tested on the original data recorded a test loss of 0.05457, an accuracy of 0.98401, and a sensitivity at specificity 0.5 of 0.99852, an AUC of 0.99747 and an F1-Score of 0.98340 as shown in the last row of Table 2).

Kernel Test Loss Accuracy Sens. at Spec. 0.5 AUC F1-Score
1 0.26417 0.88296 0.99409 0.95765 0.88333
5 0.10187 0.95893 0.99901 0.99314 0.95941
10 0.06001 0.97934 0.99926 0.99729 0.97910
15 0.06673 0.98155 0.99827 0.99663 0.98143
20 0.05831 0.98303 0.99852 0.99706 0.98278
25 0.05343 0.98131 0.99901 0.99789 0.98119
30 0.07726 0.97713 0.99704 0.99544 0.97726
Biological model 0.05457 0.98401 0.99852 0.99747 0.98340
Table 2: A selection of the metrics on the test data of the models trained with Original Training Data. Beside Accuracy, Sensitivity At Specificity 0.5, AUC and F1-Score we reported also Test loss, which represent the error between the predicted values and the actual values and is a standard metric in evaluating DL models. Values reported in last row “biological model” refer to the metrics of the full biological model given as the consensus of the single models with 20 \leq kernel \leq 30.
Refer to caption
Figure 8: Each of the 32 models, with kernel sizes varying from 1 to 31, was evaluated for test loss, accuracy, sensitivity at a specificity of 0.5, AUC and F1-Score. The resulting graphs depict a monotonic trend correlating with the increasing kernel sizes, which eventually stabilizes in the range from kernel size 20 to 31.
Synthetic Model

The evaluation of the 32 synthetic models on the synthetic dataset yielded superior metrics compared to the biological models on the training dataset. These results on the training dataset are not deemed highly significant, as overfitting not related to recording noise tends to be amplified in the augmented dataset. However, we considered significant the results of the synthetic model on non-homogeneous data. Indeed, as pointed out in Fig. 9 the synthetic model outperformed the biological model on non-homogeneous data.

Refer to caption
Figure 9: Confusion matrix for the biological and synthetic model over the non-homogeneous data labels serotonergic cells as 0 and non-serotonergic cells as 1. The matrix of the biological model (lest panel) shows the True Positive Rate 94.4% at the Top-Left; the False Negative Rate 5.6% at the Bottom-Left; the False Positive Rate 14.8% at the Top-Right; and the True Negative Rate 85.1% at the Bottom-Right. On the other hand, the matrix of the synthetic model (right panel) shows the True Positive Rate 96.2% at the Top-Left; the False Negative Rate 3.7% at the Bottom-Left; the False Positive Rate 11.1% at the Top-Right; and the True Negative Rate 88.8% at the Bottom-Right. In the table below all accuracy types of the two models over non-homogeneous data
Model Accuracy Sens. at Spec. 0.5 AUC F1-Score
Biological model 0.9125 0.8518 0.8976 0.8679
Synthetic model 0.9375 0.8888 0.9255 0.9056

4.2.2 Results on Non-homogeneous Data

The most significant outcomes were derived from non-homogeneous data, i.e., cells that were not utilized in training and that were collected on different days other than those used for the training data. Using this dataset, the biological model achieved an accuracy of 0.9125, a sensitivity at specificity of 0.5 of 0.8518, an AUC of 0.8976 and an F1-Score of 0.8679. An even better result was given by the synthetic model which achieved an accuracy of 0.9375, a sensitivity at specificity of 0.8888, an AUC of 0.9255 and an F1-Score of 0.9056. A crucial indicator of performance is the confusion matrix (refer to Fig. 9). The best results were obtained by the synthetic model. Indeed, out of 55 serotonergic cells, 53 (96.2%) were accurately identified as serotonergic (True Positive), while 2 (3.8%) were incorrectly classified as non-serotonergic (False Negative). Conversely, of the 27 non-serotonergic cells, 24 (88.8%) were correctly recognized (True Negative), and 3 (11.1%) were erroneously labeled as serotonergic (False Positive). The biological model had similar results but misclassified 3 (5.5%) serotonergic cells as non-serotonergic an 4 (14.8%) non-serotonergic cell as serotonergic. In the non-homogeneous data the False Positive Rate is higher than the False Negative Rate. We do not have explanation for this phenomenon other than randomness. Indeed, in the original data, the False Positive and False Negative Rates are similar, and this phenomenon is not present when testing either the biological or synthetic models.

Refer to caption
Figure 10: The above images are Gradient-weighted Class Activation Mapping (Grad-CAM) visualisations that highlight the regions of the input signal deemed most significant by the first convolutional layer (Conv2D) of the biological model for the classification of three serotonergic and three non-serotonergic cells. Although not a definitive pattern, the model tends to focus more on the initial portion of the signal, particularly the spike. In each panel, the left scale indicates the time step of the input signal, while the right colour scale shows the activation intensity within the Conv2D layer’s neurons.

5 Discussion

Deep-learning based models have gained increasing importance in biomedicine for their high performance in image processing and morphological recognition of cells that can be applied both in clinical diagnostics (Johansen et al., 2016; Litjens et al., 2017; Rácz et al., 2020) and in preclinical research when complex patterns of data need to be measured, classified and interpreted (De Luca et al., 2023). More specifically, convolutional neural networks (CNN) effectively address complex pattern recognition especially when patterns are hidden across varying scales and orders of magnitude. This is highly relevant in neuronal action potentials, where the peak impulse and the rise of the spike may occur in a fraction of millisecond, whereas the interval between spikes can be vastly longer. The here proposed model provides an important proof of concept for usefulness of CNN for identification of neuron types in the central nervous system on the basis of their spiking activity. To the best of our knowledge, this is the first time that this type of architecture is applied to recognition of neuronal action potentials by their recorded traces. Moreover, the recognition of serotonergic neurons has been validated by an independent identification of the recorded neuron by its serotonin neuron specific expression of a fluorescent protein.

5.1 Comparison with existing procedures for serotonergic neuron identification from their physiological activity

Identification of different neurons active in a restricted brain area on the basis of their spike shapes may be a valid and sufficient criterion when the characteristics of spikes can reliably be separated in different classes. For instance, Tseng and Han (2021) recorded in vivo the activity of behavioural-task responsive neurons of prefrontal cortex in mice and discriminated excitatory and inhibitory neurons taking advantage of the known, clearcut, difference in the duration of spikes in the two classes of neurons. In contrast, our DL based model finds its application when the characteristics of spikes from different neurons overlap as for serotonergic and non-serotonergic neurons of the dorsal raphe nucleus. Indeed, automatic routines for online measurements of action potentials can be designed, however until now no valid criteria for discriminating between spikes generated by serotonergic and non-serotonergic neurons have been established. Recognition of serotonergic neurons during extracellular recordings relies mostly on visual evaluation of the shape of the spike, that is often polyphasic, combined with the regular firing activity at relatively low frequency (up to 3-4 Hz). Thus, the mean criterion is mainly based on the asymmetric proportion between the upstroke and the downstroke of the spike (with a ratio usually >>2.5) and duration of the spike itself after the main upstroke (usually accepted in the range >> 1.2 ms). Coexistence of these characteristics is sufficient to enable an experienced Researcher to identify typical serotonergic neurons with a high degree of confidence. Nevertheless, in our recordings from genetically identified serotonergic neurons we noticed relatively frequent deviations from these criteria. Indeed, the spike duration of several neurons was less than 0.9 ms, down to 0.4-0.5 ms (see Fig. 6 in Mlinar et al., 2016). Similarly, a not negligible percentage of non-serotonergic neurons displayed spike shape and firing characteristics different from the expected biphasic, symmetric spikes of brief duration (<<0.5-0.6 ms) and high frequency, often irregular, firing. Thus, some non-serotonergic neurons show long and asymmetric action potentials and sometimes have a regular, low frequency activity (<<4 Hz) which makes their recognition difficult. Therefore, while “typical” serotonergic and non-serotonergic neurons are relatively easy to be discriminated with the currently accepted criteria a number of serotonergic neurons that do not comply with the classically established recognition criteria are discarded and not studied for their pharmacological and physiological characteristics.

Given these limits of the online visual recognition of serotonergic neurons, our model provides a valid tool for the intra-experiment identification of neurons recorded in the dorsal raphe nucleus, as the model can be implemented in the initial routine of in vitro recordings. Notably, our DL biological model relies only on spike shape for recognition of serotonin neurons and therefore it enables the identification and investigation of subpopulations of serotonergic neurons displaying irregular firing or low frequency oscillatory patterns of firing (see e.g. Mlinar et al., 2016).

5.2 Characteristics and limits of the model for its application

For the identification of serotonergic neurons we relied on transgenic mice lines that express fluorescent marker proteins under the control of serotonergic system-specific Tph2 and Pet-1 promoters. While the Tph2 promoter-driven expression of fluorescent reporter genes is expected to unmistakably label serotonergic neurons, there is a possibility that the Pet-1 Cre-based method does not label few serotonergic neurons in the DRN (see in Mlinar et al., 2016 for more detailed discussion and references). In the present context we used both promoters and the probability that these rare neurons participated in the training of the model is very low. In this unlikely case, as these non fluorescent cells were not categorized as serotonergic neurons during the model training, this specific serotonergic neuron subtype would probably be misclassified by the model.

It should be mentioned that the present model applies to the specific recording method used in collecting our database of action potentials. Thus, for immediate application of the model the sampling frequency should be set at 40 kHz. Our data were acquired using the Clampex program in loose-seal cell attached patch clamp mode, but since the routine transforms the signals in *.csv files any acquisition program that produces files in a format that can be transformed in *.csv format would provide adequate input for the model. The amplitude of the recorded current should be greater than the detection threshold that we have imposed in the model to minimize acquisition of small transients (>>50 pA). Finally, our recordings were performed at the temperature of ~37 °C. Although small deviations from this temperature could be tolerated, it should be considered that the width of the action potential, may be influenced by temperature. Notwithstanding these limitations, if the sampling rate is adequate and the signal reaches the detection amplitude the model provides an answer on neuron type with an accuracy of >>91.2% within an inference time of a few milliseconds after the submission of the recorded traces (the inference time is the raw time taken by the model in classifying the signal without considering the latent time of converting and transmitting the signal to the model which can vary depending on the user interface chosen in the deployment of the model).

It is noteworthy that in several experiments ( 30%\sim 30\% of those used here) used for training the model we applied a gentle suction in the patch pipette during the recording to improve the signal to noise ratio. We have previously shown (Mlinar et al., 2016) that this procedure does not alter the shape and duration of the recorded signals. In our context, this intra-experiment change in the amplitude of events recorded from the same neuron increases the robustness of the training data because implemented the model with events of constant shape but different weight of the background noise on the recorded signal. On the other hand, this was probably one source of the overfitting found in the initial, preliminary, model where the processed spike traces were longer (7 ms) than those used in the final models (4 ms). Indeed, in the presence of small and larger spikes with the same noise the DL processing could have retained the background noise as a signature of serotonergic neurons in addition to their shape and therefore this may explain the improvement of the model obtained by shortening the traces to be processed and limiting the recognition process to the action potential shape. Notably, our synthetic model in which various background masks were superimposed to 4 ms spikes did not significantly improve the metrics compared to those of the biological model obtained using original 4 ms spikes, confirming that limiting the DL process to the spike was sufficient to eliminate the overfitting caused by the background recognition together with the action potential shape for categorizing of neuron type. For this reason we considered sufficient to limit the model to recognition of short events and we did not include other parameters such as e.g. those defining the firing rhythm, in spite of the biological importance of this neuronal property. Indeed, our preliminary results (section 3.1) indicated that long segments of recording (e.g. 7 s), needed to allow the incorporation of periodicity of events in the model, resulted detrimental for the accuracy of the model itself. On the other hand, if deemed necessary for improving the accuracy and/or the complexity of the neuron classification, additional models directed to discriminate different, complementary, characteristics of each neuron class could be developed and then merged in a more refined model. For instance, a subset of putative serotonergic neurons recorded in vivo displays complex firing in doublets or triplets (Hajos et al., 1995). Unfortunately, this specific activity is seldom observed in slices and our dataset of in vitro recordings from genetically identified serotonergic neurons does not include any neuron with firing in doublets or triplets. Thus, our model may result not adequate to classify these neurons as serotonergic and should be modified to comply with this need. Nevertheless, it is likely that such neurons would not be missed even by our model developed to recognize single spikes because the interval between the two spikes in a doublet is usually greater than 3 ms (Hajos et al., 1995). Thus, the first spike will be fully comprised in the 4 ms detection window (of which \sim3 ms after upstroke) and recognized before the beginning of the second spike. In addition, when solitary spikes flank the doublets the recognition can be confirmed on these spikes. Thus, with minor fine tuning of parameters during training, the deep-learning procedure here described would be set to recognize also burst-firing neurons. Altogether these considerations suggest that robust models based on CNN deep-learning procedures could be developed for specific application in conditions of recording where spikes of different amplitudes and possibly slightly variable shapes could be recorded from the same neuron as typical for in vivo recordings while the neuron is approached by a micropipette or in long duration recordings. The favourable characteristic of the model is that recognition of the neuron type can be performed at the beginning of the experiment on a limited number of spikes until the neuron is classified. Similarly, these models may be applied in high-density recordings in which special probes (e.g. silicon probes) allow simultaneous recording of hundreds of neurons in brain areas where different neuron types coexist. A model trained to recognize spikes from specific neurons would enable very rapid identification of the neurons captured in the different recording channels.

Perspectives

Importantly, a relatively low number of recordings was sufficient to develop our deep-learning based model. In perspective, the procedure we describe can be applied to construct further models for the identification of other spontaneously active monoaminergic neurons. For instance, our approach with genetically fluorescent mice can be extended to the recognition of other neurons for in vitro recordings. Similarly, application of the CNN deep-learning procedure to neuronal types recognized with optogenetic methods (Liu et al., 2014) or with post-hoc immunohistochemistry (Allers and Sharp, 2003) in vivo may enable to construct a template of models capable to recognize a variety of neurons during in vivo recordings from mouse and rats. Once validated, these models would allow rapid identification of the recorded neuron, making in vivo recording of the activity of selected neurons more feasible and less demanding than at present. This may also facilitate studies on the correlation between the firing of different neuron types and behavioural responses in laboratory animals and increase our understanding of the physiological role of these neurons in modulating higher brain functions.

In conclusion, our model provides the first proof of concept that neurons can be recognized from the sole characteristics of extracellularly recorded action potentials and independently of their firing rhythm. Our model could readily be applied for intra-experiment decision making on the experimental design to apply to record that specific neuron and/or for helping the training of young Researchers at the beginning of their experience.

6 Acknowledgments

The original recordings and measurements of the action potentials were performed by Dr. Boris Mlinar and Dr. Alberto Montalbano.

7 References

Allers, K.A., Sharp, T., 2003. Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo. Neuroscience, 122(1),193-204. doi:10.1016/s0306-4522(03)00518-9.

Andrade, R., Haj-Dahmane, S., 2013. Serotonin neuron diversity in the dorsal raphe. ACS Chem Neurosci. 4(1), 22-5. doi: 10.1021/cn300224n.

Baraban, J.M. and Aghajanian, G.K., 1980. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19, 355–363. doi:10.1016/0028-3908(80) 90187-2

Calizo, L. H.; Akanwa, A.; Ma, X.; Pan, Y.; Lemos, J. C.; Craige, C.; Heemstra, L. A.; Beck, S. G., 2011. Raphe Serotonin Neurons Are Not homogeneous: Electrophysiological, Morphological and Neurochemical Evidence. Neuropharmacology, 61 (3), 524−543. doi:10.1016/j.neuropharm.2011.04.008

Commons, K.G., 2020. Dorsal raphe organization. J Chem Neuroanat. 110, 101868. doi: 10.1016/j.jchemneu.2020.101868.

De Luca, D., Moccia, S., Lupori, L., Mazziotti, R., Pizzorusso, T., Micera, S., 2023. Convolutional neural network classifies visual stimuli from cortical response recorded with wide-field imaging in mice. J Neural Eng. 20(2), 026031. doi:10.1088/1741-2552/acc2e7.

Faulkner, P., Deakin, J.F., 2014.The role of serotonin in reward, punishment and behavioural inhibition in humans: insights from studies with acute tryptophan depletion. Neurosci Biobehav Rev. 46 Pt 3:365-78. doi:10.1016/j.neubiorev.2014.07.024.

Gaspar P, Lillesaar C. Probing the diversity of serotonin neurons. Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2382-94. doi:10.1098/rstb.2011.0378.

Hajós, M., Gartside, S.E., Villa, A.E., Sharp, T., 1995 Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat. Neuroscience 69(1):189-97. doi:10.1016/0306-4522(95)00227-a.

Johansen, A.R., Jin, J., Maszczyk, T., Dauwels, J., Cash, S.S., Westover, M.B., 2016. Epileptiform Spike Detection Via Convolutional Neural Networks. Proc IEEE Int Conf Acoust Speech Signal Process. March 2016, 754-758. doi: 10.1109/ICASSP.2016.7471776.

Lesch, K.P., Araragi, N., Waider, J., van den Hove, D., Gutknecht, L., 2012. Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour. Philos Trans R Soc Lond B Biol Sci. 367(1601), 2426-43. doi:10.1098/rstb.2012.0039.

Levine, E.S., Jacobs, B.L., 1992. Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microiontophoretic studies in the awake cat. J. Neurosci. 12, 4037–4044. doi:10.1523/JNEUROSCI.12-10-04037.1992

Litjens, G., Kooi, T., Bejnordi, B.E., Setio, A.A.A., Ciompi, F., Ghafoorian, M., van der Laak, J.A.W.M., van Ginneken, B., Sánchez, C.I., 2017. A survey on deep learning in medical image analysis. Med Image Anal. 42, 60-88. https://doi.org/ 10.1016/j.media.2017.07.005.

Liu, Z., Zhou, J., Li, Y., Hu, F., Lu, Y., Ma, M., Feng, Q., Zhang, J.E., Wang, D., Zeng, J., Bao, J., Kim, J.Y., Chen, Z.F., El Mestikawy, S., Luo, M., 2014. Dorsal raphe neurons signal reward through 5-HT and glutamate. Neuron. 81(6),1360-1374. doi:10.1016/j.neuron.2014.02.010.

Liu, Y., 2018. Feature Extraction and Image Recognition with Convolutional Neural Networks. Journal of Physics: Conference Series, 1087. https://doi.org/10.1088/1742-6596/1087/6/062032.

Liu, L., Yang, S., & Shi, D., 2019. Advanced Convolutional Neural Network With Feedforward Inhibition. 2019 International Conference on Machine Learning and Cybernetics (ICMLC), 1-5. https://doi.org/10.1109/ICMLC48188.2019.8949229.

Mlinar, B., Montalbano, A., Piszczek, L., Gross, C., Corradetti, R., 2016. Firing properties of genetically identified dorsal raphe serotonergic neurons in brain slices. Front. Cell Neurosci. 10, 195. doi:10.3389/fncel.2016.00195

Montalbano, A., Waider, J., Barbieri, M., Baytas, O., Lesch, K.P., Corradetti, R., Mlinar, B., 2015. Cellular resilience: 5-HT neurons in Tph2 (-/-) mice retain normal firing behaviour despite the lack of brain 5-HT. Eur. Neuropsychopharmacol. 25, 2022–2035. doi:10.1016/j.euroneuro.2015.08.021

Monti, J.M., 2011. Serotonin control of sleep-wake behavior. Sleep Med Rev. 15(4), 269-81. doi: 10.1016/j.smrv.2010.11.003.

Mosko, S.S., Jacobs, B.L., 1974. Midbrain raphe neurons: spontaneous activity and response to light. Physiol. Behav. 13, 589–593. doi:10.1016/0031-9384(74)90292-3

Mosko, S.S., Jacobs, B.L., 1976. Recording of dorsal raphe unit activity in vitro. Neurosci. Lett. 2: 195–200.doi:10.1016/0304-3940(76)90014-8

Paquelet, G.E., Carrion, K., Lacefield, C.O,, Zhou, P., Hen, R., Miller, B.R., 2022. Single-cell activity and network properties of dorsal raphe nucleus serotonin neurons during emotionally salient behaviors. Neuron 110(16), 2664-2679.e8. doi: 10.1016/j.neuron.2022.05.015.

Pilowsky, P.M., 2014. Peptides, serotonin, and breathing: the role of the raphe in the control of respiration. Prog Brain Res. 209, 169-89. doi:10.1016/B978-0-444-63274-6.00009-6.

Rácz, M., Liber, C., Németh, E., Fiáth, R., Rokai, J., Harmati, I., Ulbert, I., Márton, G., 2020. Spike detection and sorting with deep learning. J Neural Eng. 17(1):016038. doi: 10.1088/1741-2552/ab4896.

Steinbusch, H.W.M., Dolatkhah, M.A., Hopkins, D.A., 2021. Anatomical and neurochemical organization of the serotonergic system in the mammalian brain and in particular the involvement of the dorsal raphe nucleus in relation to neurological diseases. Prog Brain Res. 261, 41-81. doi: 10.1016/bs.pbr.2021.02.003.

Tseng, H.A., Han, X., 2021. Distinct Spiking Patterns of Excitatory and Inhibitory Neurons and LFP Oscillations in Prefrontal Cortex During Sensory Discrimination. Front. Physiol. 12:618307. doi: 10.3389/fphys.2021.618307.

Vandermaelen, C.P., Aghajanian, G.K., 1983. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly andintracellularly in rat brain slices. Brain Res. 289, 109–119. doi: 10.1016/0006-8993(83)90011-2.

8 Data Sharing Statement

The data and source code correspondent to the analyses contained in this manuscript are publicly available from: Corradetti et al. 2024 Repository with all data available at

GitHub.com/neuraldl/DLAtypicalSerotoninergicCells/tree/main

9 Author Contributions

All authors have made a significant contribution to the idea formation, study design, data curation, analysis and interpretation. D.C. & R.C. wrote and reviewed the manuscript. R.C. collected and selected the data. A.B. and D.C. realised the software for both the neural networks and the synthetic data generation.